Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation programme
Prioritisation programme
HealthTech (1)
Interventional procedures (1)
Medicines evaluation (8)
None selected (102)
Decision
Decision
Awaiting decision (6)
Further information required (3)
Not selected (102)
Apply filters
Showing 31 to 40 of 112
Sort by
Decision date
Title
Apply sorting
Keyword or reference number: in
`Remove $Keyword or reference number: in filter`
Topic prioritisation
Title
Prioritisation programme
Decision
Decision date
Veverimer for treating metabolic acidosis
in
chronic kidney disease [ID3832]
None selected
Awaiting decision
14 March 2025
Linaclotide acetate for treating functional constipation
in
people 6 to 17 years [TSID12125]
None selected
Not selected
5 March 2025
Vedolizumab for treating moderately to severely active ulcerative colitis
in
people 2 to 17 years [TSID12134]
None selected
Not selected
5 March 2025
High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus
in
high risk or immunocompromised patients
None selected
Awaiting decision
5 February 2025
Clindamycin for treating bacterial vaginosis
in
females aged 12 and older [TSID 12127]
None selected
Not selected
4 February 2025
Ustekinumab for treating moderately to severely active ulcerative colitis
in
children aged 2 to 17 years [TSID 12128]
None selected
Not selected
4 February 2025
Berotralstat for preventing recurrent attacks of hereditary angioedema
in
children aged 2 to 12 years [TSID 12132]
None selected
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis
in
children [TSID12133]
None selected
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis
in
children [TSID 12133_TSID 12135]
None selected
Not selected
4 February 2025
Avatrombopag for treating primary chronic immune thrombocytopenia
in
people 1 to 17 years [TSID12109]
None selected
Not selected
17 December 2024
Previous page
1
2
3
Current page
4
5
6
…
12
Page
4
of
12
Next page
Results per page
10
25
50
All
Back to top